ClinVar Miner

Submissions for variant NM_001018115.3(FANCD2):c.99_102del (p.Lys33fs)

dbSNP: rs1283566463
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Revvity Omics, Revvity RCV001783254 SCV002022339 pathogenic Fanconi anemia complementation group D2 2019-05-20 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV001783254 SCV002777771 pathogenic Fanconi anemia complementation group D2 2021-11-16 criteria provided, single submitter clinical testing
Invitae RCV003772136 SCV004622118 pathogenic Fanconi anemia 2023-11-09 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Lys33Asnfs*16) in the FANCD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCD2 are known to be pathogenic (PMID: 17436244). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FANCD2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1322879). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.